298 related articles for article (PubMed ID: 23283524)
1. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
Zhang X; Tworoger SS; Eliassen AH; Hankinson SE
Breast Cancer Res Treat; 2013 Feb; 137(3):883-92. PubMed ID: 23283524
[TBL] [Abstract][Full Text] [Related]
2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
4. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
[TBL] [Abstract][Full Text] [Related]
5. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
7. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
[TBL] [Abstract][Full Text] [Related]
9. Serum sex hormone levels after menopause and subsequent breast cancer.
Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G
J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008
[TBL] [Abstract][Full Text] [Related]
10. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
[TBL] [Abstract][Full Text] [Related]
12. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
13. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
[TBL] [Abstract][Full Text] [Related]
14. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.
Woolcott CG; Shvetsov YB; Stanczyk FZ; Wilkens LR; White KK; Caberto C; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Endocr Relat Cancer; 2010 Mar; 17(1):125-34. PubMed ID: 19903744
[TBL] [Abstract][Full Text] [Related]
15. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
[TBL] [Abstract][Full Text] [Related]
19. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
[TBL] [Abstract][Full Text] [Related]
20. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Manson JE; Colditz GA; Hunter DJ; Spiegelman D; Barbieri RL; Speizer FE
J Natl Cancer Inst; 1998 Sep; 90(17):1292-9. PubMed ID: 9731736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]